Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: AC Immune(ACIU) the Revenue is 18.72 M (+1046%), Miss estimate;the EBIT is 1.478 M (+106.1%), Miss estimate;the EPS is 0.0248 (+109.4%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.02B1046.42%
0.03B1990.00%
-0.02B943.58%
EBITMiss expectations
0.00B106.10%
0.02B166.03%
-0.01B59.93%
EPSMiss expectations
0.0248109.44%
0.1214146.23%
-0.096636.79%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf